After treating a tumor with chemotherapy and radiotherapy, cells known as senescent cells can appear. These are cells that do not divide, are involved in the aging process, and are resistant to cell death, but are still metabolically active in the human body. When they accumulate, they can jeopardize the patients’ recovery. Now, a UB-led study describes for the first time a molecular mechanism that could drive the design of strategies to eliminate senescent cells in cancer patients.
2025
Air Pollution Exposure May Be Protective for Melanoma Risk
WEDNESDAY, Jan. 22, 2025 (HealthDay News) — Exposure to particulate matter (PM) with diameters of 10 µm (PM10) or with diameters that are 2.5 µm or smaller (PM2.5) seems to have a protective effect on melanoma risk, potentially due to the reduction in ultraviolet radiation exposure, according to a study published online Jan. 17 in the Journal of the European Academy of Dermatology and Venereology.
How New Research Is Redefining Melanoma Treatment
The treatment landscape for melanoma saw significant advancements in 2024, as highlighted by Elisa Funck-Brentano, MD, PhD, from Ambroise-Paré Hospital in Paris, France, during her presentation at the 2024 Dermatology Days of Paris conference in Paris.
Melanoma metastasis: Research unveils the cell death pathway in bone
Melanoma, one of the most aggressive forms of skin cancer, often metastasizes to bones, causing severe bone loss, an increased risk of fractures, and significant pain. Bone metastasis is associated with poor survival rates and a markedly reduced quality of life.